IKKβ in intestinal mesenchymal cells promotes initiation of colitis-associated cancer

Journal of Experimental Medicine

Volumn 212, Issue 13, 2015, Pages 2235-2251

  Koliaraki, Vasiliki ^a   Pasparakis, Manolis ^b   Kollias, George ^a,c  

^a BIOMEDICAL SCIENCES RESEARCH CENTER ALEXANDER FLEMING   (Greece)

^b UNIVERSITY OF COLOGNE   (Germany)

^c UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

DEXTRAN SULFATE; I KAPPA B KINASE BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; STAT3 PROTEIN; AUTACOID; COLLAGEN TYPE 6; CYTOKINE; I KAPPA B KINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER STAGING; CARCINOGENESIS; CELL INFILTRATION; CELL PROLIFERATION; COLORECTAL CANCER; CONTROLLED STUDY; CYTOKINE PRODUCTION; DEXTRAN SODIUM SULFATE-INDUCED COLITIS; DISEASE ASSOCIATION; EPITHELIUM DYSPLASIA; EX VIVO STUDY; IMMUNOCOMPETENT CELL; INFLAMMATION; INNATE IMMUNITY; INTESTINAL MESENCHYMAL CELL; INTESTINE CELL; INTESTINE EPITHELIUM CELL; MEDIATOR RELEASE; MESENCHYME CELL; MOLECULAR PATHOLOGY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; ANIMAL; APOPTOSIS; BIOSYNTHESIS; C57BL MOUSE; CELL LINEAGE; COLITIS; COLORECTAL TUMOR; EPITHELIUM CELL; GENE DELETION; INTESTINE; KNOCKOUT MOUSE; MESODERM; METABOLISM; PARACRINE SIGNALING; PATHOLOGY; PHOSPHORYLATION; SOLUBILITY;

ANIMALS; APOPTOSIS; CARCINOGENESIS; CELL LINEAGE; CELL PROLIFERATION; COLITIS; COLLAGEN TYPE VI; COLORECTAL NEOPLASMS; CYTOKINES; DEXTRAN SULFATE; EPITHELIAL CELLS; GENE DELETION; I-KAPPA B KINASE; IMMUNITY, INNATE; INFLAMMATION; INFLAMMATION MEDIATORS; INTESTINES; MESODERM; MICE, INBRED C57BL; MICE, KNOCKOUT; NF-KAPPA B; PARACRINE COMMUNICATION; PHOSPHORYLATION; SIGNAL TRANSDUCTION; SOLUBILITY; STAT3 TRANSCRIPTION FACTOR;

EID: 84956878669     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20150542     Document Type: Article

References (40)

1. Armaka, M., M. Apostolaki, P. Jacques, D.L. Kontoyiannis, D. Elewaut, and G. Kollias. 2008. Mesenchymal cell targeting by TNF as a common pathogenic principle in chronic inflammatory joint and intestinal diseases. J. Exp. Med. 205:331-337. http://dx.doi.org/10.1084/jem.20070906
2. Becker, C., M.C. Fantini, C. Schramm, H.A. Lehr, S. Wirtz, A. Nikolaev, J. Burg, S. Strand, R. Kiesslich, S. Huber, et al. 2004. TGF-beta suppresses tumor progression in colon cancer by inhibition of IL-6 trans-signaling. Immunity. 21:491-501. http://dx.doi.org/10.1016/j.immuni.2004.07.020
3. Ben-Neriah, Y., and M. Karin. 2011. Inflammation meets cancer, with NF-κB as the matchmaker. Nat. Immunol. 12:715-723. http://dx.doi.org/10.1038/ni.2060
4. Bhowmick, N.A., A. Chytil, D. Plieth, A.E. Gorska, N. Dumont, S. Shappell, M.K. Washington, E.G. Neilson, and H.L. Moses. 2004. TGF-beta signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia. Science. 303:848-851. http://dx.doi.org/10.1126/science.1090922
5. Bollrath, J., T.J. Phesse, V.A. von Burstin, T. Putoczki, M. Bennecke, T. Bateman, T. Nebelsiek, T. Lundgren-May, O. Canli, S. Schwitalla, et al. 2009. gp130-mediated Stat3 activation in enterocytes regulates cell survival and cellcycle progression during colitis-associated tumorigenesis. Cancer Cell. 15:91-102. http://dx.doi.org/10.1016/j.ccr.2009.01.002
6. Clevers, H. 2004. At the crossroads of inflammation and cancer. Cell. 118:671-674. http://dx.doi.org/10.1016/j.cell.2004.09.005
7. Cooper, H.S., L. Everley, W.C. Chang, G. Pfeiffer, B. Lee, S. Murthy, and M.L. Clapper. 2001. The role of mutant Apc in the development of dysplasia and cancer in the mouse model of dextran sulfate sodium-induced colitis. Gastroenterology. 121:1407-1416. http://dx.doi.org/10.1053/gast.2001.29609
8. DiDonato, J.A., F. Mercurio, and M. Karin. 2012. NF-κB and the link between inflammation and cancer. Immunol. Rev. 246:379-400. http://dx.doi.org/10.1111/j.1600-065X.2012.01099.x
9. Eckmann, L., T. Nebelsiek, A.A. Fingerle, S.M. Dann, J. Mages, R. Lang, S. Robine, M.F. Kagnoff, R.M. Schmid, M. Karin, et al. 2008. Opposing functions of IKKbeta during acute and chronic intestinal inflammation. Proc. Natl. Acad. Sci. USA. 105:15058-15063. http://dx.doi.org/10.1073/pnas.0808216105
10. Erez, N., M. Truitt, P. Olson, S.T. Arron, and D. Hanahan. 2010. Cancer-Associated Fibroblasts Are Activated in Incipient Neoplasia to Orchestrate Tumor-Promoting Inflammation in an NF-kappaB-Dependent Manner. Cancer Cell. 17:135-147. http://dx.doi.org/10.1016/j.ccr.2009.12.041
11. Fodde, R., W. Edelmann, K. Yang, C. van Leeuwen, C. Carlson, B. Renault, C. Breukel, E. Alt, M. Lipkin, P.M. Khan, et al. 1994. A targeted chaintermination mutation in the mouse Apc gene results in multiple intestinal tumors. Proc. Natl. Acad. Sci. USA. 91:8969-8973. http://dx.doi.org/10.1073/pnas.91.19.8969
12. Fukata, M., A. Chen, A.S. Vamadevan, J. Cohen, K. Breglio, S. Krishnareddy, D. Hsu, R. Xu, N. Harpaz, A.J. Dannenberg, et al. 2007. Toll-like receptor-4 promotes the development of colitis-associated colorectal tumors. Gastroenterology. 133:1869-1881. http://dx.doi.org/10.1053/j.gastro .2007.09.008
13. Fukata, M., Y. Hernandez, D. Conduah, J. Cohen, A. Chen, K. Breglio, T. Goo, D. Hsu, R. Xu, and M.T. Abreu. 2009. Innate immune signaling by Tolllike receptor-4 (TLR4) shapes the inflammatory microenvironment in colitis-associated tumors. Inflamm. Bowel Dis. 15:997-1006. http://dx.doi.org/10.1002/ibd.20880
14. Fukata, M., L. Shang, R. Santaolalla, J. Sotolongo, C. Pastorini, C. España, R. Ungaro, N. Harpaz, H.S. Cooper, G. Elson, et al. 2011. Constitutive activation of epithelial TLR4 augments inflammatory responses to mucosal injury and drives colitis-associated tumorigenesis. Inflamm. Bowel Dis. 17:1464-1473. http://dx.doi.org/10.1002/ibd.21527
15. Greten, F.R., L. Eckmann, T.F. Greten, J.M. Park, Z.W. Li, L.J. Egan, M.F. Kagnoff, and M. Karin. 2004. IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell. 118:285-296. http://dx.doi.org/10.1016/j.cell.2004.07.013
16. Grivennikov, S., E. Karin, J. Terzic, D. Mucida, G.Y. Yu, S. Vallabhapurapu, J. Scheller, S. Rose-John, H. Cheroutre, L. Eckmann, and M. Karin. 2009. IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer. Cancer Cell. 15:103-113. http://dx.doi.org/10.1016/j.ccr.2009.01.001
17. Grivennikov, S.I., F.R. Greten, and M. Karin. 2010. Immunity, inflammation, and cancer. Cell. 140:883-899. http://dx.doi.org/10.1016/j.cell.2010.01.025
18. Hanahan, D., and L.M. Coussens. 2012. Accessories to the crime: functions of cells recruited to the tumor microenvironment. Cancer Cell. 21:309-322. http://dx.doi.org/10.1016/j.ccr.2012.02.022
19. Hanahan, D., and R.A. Weinberg. 2011. Hallmarks of cancer: the next generation. Cell. 144:646-674. http://dx.doi.org/10.1016/j.cell.2011.02.013
20. Hayakawa, Y., S. Maeda, H. Nakagawa, Y. Hikiba, W. Shibata, K. Sakamoto, A. Yanai, Y. Hirata, K. Ogura, S. Muto, et al. 2009. Effectiveness of IkappaB kinase inhibitors in murine colitis-associated tumorigenesis. J. Gastroenterol. 44:935-943. http://dx.doi.org/10.1007/s00535-009-0098-7
21. Kalluri, R., and M. Zeisberg. 2006. Fibroblasts in cancer. Nat. Rev. Cancer. 6:392-401. http://dx.doi.org/10.1038/nrc1877
22. Koliaraki, V., M. Roulis, and G. Kollias. 2012. Tpl2 regulates intestinal myofibroblast HGF release to suppress colitis-associated tumorigenesis. J. Clin. Invest. 122:4231-4242. http://dx.doi.org/10.1172/JCI63917
23. Li, Q., D. Van Antwerp, F. Mercurio, K.F. Lee, and I.M. Verma. 1999. Severe liver degeneration in mice lacking the IkappaB kinase 2 gene. Science. 284:321-325. http://dx.doi.org/10.1126/science.284.5412.321
24. Liu, F., Y. Xia, A.S. Parker, and I.M. Verma. 2012. IKK biology. Immunol. Rev. 246:239-253. http://dx.doi.org/10.1111/j.1600-065X.2012.01107.x
25. Mantovani, A., P. Allavena, A. Sica, and F. Balkwill. 2008. Cancer-related inflammation. Nature. 454:436-444. http://dx.doi.org/10.1038/nature07205
26. Mifflin, R.C., I.V. Pinchuk, J.I. Saada, and D.W. Powell. 2011. Intestinal myofibroblasts: targets for stem cell therapy. Am. J. Physiol. Gastrointest. Liver Physiol. 300:G684-G696. http://dx.doi.org/10.1152/ajpgi.00474.2010
27. Muzumdar, M.D., B. Tasic, K. Miyamichi, L. Li, and L. Luo. 2007. A global double-fluorescent Cre reporter mouse. Genesis. 45:593-605. http://dx.doi.org/10.1002/dvg.20335
28. Neufert, C., C. Becker, and M.F. Neurath. 2007. An inducible mouse model of colon carcinogenesis for the analysis of sporadic and inflammationdriven tumor progression. Nat. Protoc. 2:1998-2004. http://dx.doi.org/10.1038/nprot.2007.279
29. Normand, S., A. Delanoye-Crespin, A. Bressenot, L. Huot, T. Grandjean, L. Peyrin-Biroulet, Y. Lemoine, D. Hot, and M. Chamaillard. 2011. Nodlike receptor pyrin domain-containing protein 6 (NLRP6) controls epithelial self-renewal and colorectal carcinogenesis upon injury. Proc. Natl. Acad. Sci. USA. 108:9601-9606. http://dx.doi.org/10.1073/pnas.1100981108
30. Pallangyo, C.K., P.K. Ziegler, and F.R. Greten. 2015. IKKβ acts as a tumor suppressor in cancer-associated fibroblasts during intestinal tumorigenesis. J. Exp. Med. 212:. http://dx.doi.org/10.1084/jem.20150576
31. Pasparakis, M., G. Courtois, M. Hafner, M. Schmidt-Supprian, A. Nenci, A. Toksoy, M. Krampert, M. Goebeler, R. Gillitzer, A. Israel, et al. 2002. TNF-mediated inflammatory skin disease in mice with epidermisspecific deletion of IKK2. Nature. 417:861-866. http://dx.doi.org/10.1038/nature00820
32. Popivanova, B.K., K. Kitamura, Y. Wu, T. Kondo, T. Kagaya, S. Kaneko, M. Oshima, C. Fujii, and N. Mukaida. 2008. Blocking TNF-alpha in mice reduces colorectal carcinogenesis associated with chronic colitis. J. Clin. Invest. 118:560-570.
33. Schmidt-Supprian, M., W. Bloch, G. Courtois, K. Addicks, A. Israël, K. Rajewsky, and M. Pasparakis. 2000. NEMO/IKK gamma-deficient mice model incontinentia pigmenti. Mol. Cell. 5:981-992. http://dx.doi.org/10.1016/S1097-2765(00)80263-4
34. Servais, C., and N. Erez. 2013. From sentinel cells to inflammatory culprits:cancer-associated fibroblasts in tumour-related inflammation. J. Pathol. 229:198-207.
35. Shaker, A., M. Gargus, J. Fink, J. Binkley, I. Darwech, E. Swietlicki, M.S. Levin, and D.C. Rubin. 2014. Epimorphin(-/-) mice are protected, in part, from acute colitis via decreased interleukin 6 signaling. Transl. Res. 164:70-83. http://dx.doi.org/10.1016/j.trsl.2014.03.007
36. Terzić, J., S. Grivennikov, E. Karin, and M. Karin. 2010. Inflammation and colon cancer. Gastroenterology. 138:2101-2114.e5. http://dx.doi.org/10.1053/j.gastro.2010.01.058
37. Trimboli, A.J., C.Z. Cantemir-Stone, F. Li, J.A. Wallace, A. Merchant, N. Creasap, J.C. Thompson, E. Caserta, H. Wang, J.L. Chong, et al. 2009. Pten in stromal fibroblasts suppresses mammary epithelial tumours. Nature. 461:1084-1091. http://dx.doi.org/10.1038/nature08486
38. Vandoros, G.P., P.A. Konstantinopoulos, G. Sotiropoulou-Bonikou, A. Kominea, G.I. Papachristou, M.V. Karamouzis, M. Gkermpesi, I. Varakis, and A.G. Papavassiliou. 2006. PPAR-gamma is expressed and NF-κB pathway is activated and correlates positively with COX-2 expression in stromal myofibroblasts surrounding colon adenocarcinomas. J. Cancer Res. Clin. Oncol. 132:76-84. http://dx.doi.org/10.1007/s00432-005-0042-z
39. Wirtz, S., C. Neufert, B. Weigmann, and M.F. Neurath. 2007. Chemically induced mouse models of intestinal inflammation. Nat. Protoc. 2:541-546. http://dx.doi.org/10.1038/nprot.2007.41
40. Yu, H., D. Pardoll, and R. Jove. 2009. STATs in cancer inflammation and immunity: a leading role for STAT3. Nat. Rev. Cancer. 9:798-809. http://dx.doi.org/10.1038/nrc2734